Page last updated: 2024-10-27

fluoxetine and Tremor

fluoxetine has been researched along with Tremor in 17 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.

Research Excerpts

ExcerptRelevanceReference
"Fluoxetine, a specific serotonin reuptake inhibitor, was compared to amitriptyline in the treatment of 51 outpatients with primary major depressive disorder."9.05A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. ( Chouinard, G, 1985)
"The cardinal motor symptoms of Parkinson's disease (PD) include resting tremor, akinesia, bradykinesia, and rigidity, and these motor abnormalities can be modeled in rodents by administration of the VMAT-2 (type-2 vesicular monoamine transporter) inhibitor tetrabenazine (9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7, 11b hexahydrobenzo[a]quinolizin-2-one; TBZ)."7.81Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism. ( Contreras-Mora, HM; Correa, M; Milligan, MN; Podurgiel, SJ; Purcell, LJ; Salamone, JD; Yohn, SE, 2015)
"4 years, who developed tremor after receiving fluoxetine at a mean dose of 25."7.71Fluoxetine-induced tremor: clinical features in 21 patients. ( Serrano-Dueñas, M, 2002)
"Clonidine exhibited a dose-dependent protection against harmine-induced tremors in mice."7.67Modification by clonidine of harmine-induced tremors in mice: involvement of serotoninergic system. ( Garg, SK; Kulkarni, SK; Shukla, VK, 1986)
" For individual adverse events that developed or worsened during therapy, more fluoxetine-treated patients reported rhinitis and tremor (p less than or equal to ."5.07Fluoxetine versus trazodone: efficacy and activating-sedating effects. ( Beasley, CM; Bosomworth, JC; Dornseif, BE; Pultz, JA; Sayler, ME, 1991)
"Fluoxetine, a specific serotonin reuptake inhibitor, was compared to amitriptyline in the treatment of 51 outpatients with primary major depressive disorder."5.05A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. ( Chouinard, G, 1985)
"The cardinal motor symptoms of Parkinson's disease (PD) include resting tremor, akinesia, bradykinesia, and rigidity, and these motor abnormalities can be modeled in rodents by administration of the VMAT-2 (type-2 vesicular monoamine transporter) inhibitor tetrabenazine (9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7, 11b hexahydrobenzo[a]quinolizin-2-one; TBZ)."3.81Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism. ( Contreras-Mora, HM; Correa, M; Milligan, MN; Podurgiel, SJ; Purcell, LJ; Salamone, JD; Yohn, SE, 2015)
"4 years, who developed tremor after receiving fluoxetine at a mean dose of 25."3.71Fluoxetine-induced tremor: clinical features in 21 patients. ( Serrano-Dueñas, M, 2002)
"Clonidine exhibited a dose-dependent protection against harmine-induced tremors in mice."3.67Modification by clonidine of harmine-induced tremors in mice: involvement of serotoninergic system. ( Garg, SK; Kulkarni, SK; Shukla, VK, 1986)
"To determine whether SSRIs impact disease progression, fluoxetine (Prozac, 5 or 10 mg/kg) was administered to mutant superoxide dismutase 1 (SOD1) mice during one of three age ranges: neonatal [postnatal day (P)5-11], adult presymptomatic (P30 to end stage), and adult symptomatic (P70 to end stage)."1.40Effect of fluoxetine on disease progression in a mouse model of ALS. ( Heckman, CJ; Kajtaz, E; Kocevar, EJ; Koschnitzky, JE; Lukas, TJ; Mayers, WF; Quinlan, KA; Siddique, T, 2014)
"Because of a depressive syndrome, a 39-year-old patient received 20 mg fluoxetine per day."1.29[A case of rare side effects of certain antidepressive drugs]. ( Haenel, T; Stöckli, HR; Truog, P, 1995)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19903 (17.65)18.7374
1990's9 (52.94)18.2507
2000's2 (11.76)29.6817
2010's3 (17.65)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koschnitzky, JE1
Quinlan, KA1
Lukas, TJ1
Kajtaz, E1
Kocevar, EJ1
Mayers, WF1
Siddique, T1
Heckman, CJ1
Podurgiel, SJ1
Milligan, MN1
Yohn, SE1
Purcell, LJ1
Contreras-Mora, HM1
Correa, M1
Salamone, JD1
Rittmannsberger, H1
Werl, R1
Serrano-Dueñas, M1
D'Souza, DC1
Bennett, A1
Abi-Dargham, A1
Krystal, JH1
Haenel, T1
Stöckli, HR1
Truog, P1
Fernández López, MI1
Sánchez Esteban, J1
Jímenez Belló, J1
Meseguer Zaragoza, A1
Takeuchi, H1
Yatsugi, S1
Hatanaka, K1
Nakato, K1
Hattori, H1
Sonoda, R1
Koshiya, K1
Fujii, M1
Yamaguchi, T1
Anand, KS1
Prasad, A1
Pradhan, SC1
Biswas, A1
Darko, W1
Guharoy, R1
Rose, F1
Lehman, D1
Pappas, V1
Austin, LS1
Zealberg, JJ1
Lydiard, RB1
Beasley, CM1
Dornseif, BE1
Pultz, JA1
Bosomworth, JC1
Sayler, ME1
Feighner, JP1
Boyer, WF1
Tyler, DL1
Neborsky, RJ1
Hansen, TE1
Dieter, K1
Keepers, GA1
Levine, S1
Deo, R1
Mahadevan, K1
Shukla, VK1
Garg, SK1
Kulkarni, SK1
Chouinard, G1

Trials

3 trials available for fluoxetine and Tremor

ArticleYear
Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    The Journal of clinical psychiatry, 1991, Volume: 52, Issue:7

    Topics: Adult; Akathisia, Drug-Induced; Ambulatory Care; Anxiety; Depressive Disorder; Dizziness; Double-Bli

1991
A comparative trial of a new antidepressant, fluoxetine.
    The British journal of psychiatry : the journal of mental science, 1987, Volume: 150

    Topics: Adult; Aged; Body Weight; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female

1987
A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:3 Pt 2

    Topics: Adult; Ambulatory Care; Amitriptyline; Anxiety; Body Weight; Clinical Trials as Topic; Depressive Di

1985

Other Studies

14 other studies available for fluoxetine and Tremor

ArticleYear
Effect of fluoxetine on disease progression in a mouse model of ALS.
    Journal of neurophysiology, 2014, Jun-01, Volume: 111, Issue:11

    Topics: Amyotrophic Lateral Sclerosis; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal;

2014
Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:9

    Topics: Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Rela

2015
Does aripiprazole protect from serotonin syndrome?
    Psychiatria Danubina, 2012, Volume: 24, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Borderline Pers

2012
Fluoxetine-induced tremor: clinical features in 21 patients.
    Parkinsonism & related disorders, 2002, Volume: 8, Issue:5

    Topics: Adult; Aged; Cohort Studies; Female; Fluoxetine; Humans; Male; Middle Aged; Olivary Nucleus; Red Nuc

2002
Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient.
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:5

    Topics: Akathisia, Drug-Induced; Drug Therapy, Combination; Fluoxetine; Haloperidol; Humans; Male; Middle Ag

1994
[A case of rare side effects of certain antidepressive drugs].
    Der Nervenarzt, 1995, Volume: 66, Issue:1

    Topics: Adult; Antidepressive Agents; Clomipramine; Depressive Disorder; Diagnosis, Differential; Drug Thera

1995
[Suggestive episodes of hypoglycemia related to fluoxetine].
    Atencion primaria, 1996, Volume: 18, Issue:10

    Topics: Adult; Diabetes Mellitus, Type 2; Diagnosis, Differential; Dizziness; Female; Fluoxetine; Humans; Hy

1996
Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity.
    European journal of pharmacology, 1997, Jun-18, Volume: 329, Issue:1

    Topics: Animals; Citalopram; Fluoxetine; Learning; Mice; Mice, Inbred ICR; Morpholines; Olfactory Bulb; Oxot

1997
Fluoxetine-induced tremors.
    The Journal of the Association of Physicians of India, 1999, Volume: 47, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Diagnosis, Differential; Female; Fluoxetine; Humans

1999
Myoclonus secondary to the concurrent use of trazodone and fluoxetine.
    Veterinary and human toxicology, 2001, Volume: 43, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Drug Synergism; Fluoxetine; HIV Infecti

2001
Three cases of pharmacotherapy of obsessive-compulsive disorder in the elderly.
    The Journal of nervous and mental disease, 1991, Volume: 179, Issue:10

    Topics: Age Factors; Aged; Clomipramine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Tr

1991
Adverse consequences of fluoxetine-MAOI combination therapy.
    The Journal of clinical psychiatry, 1990, Volume: 51, Issue:6

    Topics: Adult; Akathisia, Drug-Induced; Confusion; Depressive Disorder; Drug Interactions; Drug Therapy, Com

1990
Interaction of fluoxetine and pentazocine.
    The American journal of psychiatry, 1990, Volume: 147, Issue:7

    Topics: Adult; Anxiety; Ataxia; Drug Interactions; Fluoxetine; Humans; Hypertension; Male; Nausea; Paresthes

1990
Modification by clonidine of harmine-induced tremors in mice: involvement of serotoninergic system.
    Archives internationales de pharmacodynamie et de therapie, 1986, Volume: 282, Issue:1

    Topics: Alkaloids; Animals; Clonidine; Cyproheptadine; Fluoxetine; Harmine; Male; Mice; Quipazine; Serotonin

1986